UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
34.54
+0.16 (0.47%)
At close: Jun 26, 2026, 4:00 PM EDT
34.10
-0.44 (-1.27%)
After-hours: Jun 26, 2026, 7:02 PM EDT
UroGen Pharma Employees
UroGen Pharma had 291 employees as of December 31, 2025. The number of employees increased by 56 or 23.83% compared to the previous year.
Employees
291
Change (1Y)
56
Growth (1Y)
23.83%
Revenue / Employee
$471,453
Profits / Employee
-$447,064
Market Cap
1.68B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Recursion Pharmaceuticals | 600 |
| Vir Biotechnology | 367 |
| Zymeworks | 243 |
| Capricor Therapeutics | 231 |
| Innoviva | 159 |
| Septerna | 130 |
| AnaptysBio | 104 |
URGN News
- 4 days ago - UroGen Pharma Transcript: AGM 2026 - Transcripts
- 16 days ago - UroGen Pharma Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 21 days ago - UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - UroGen Announces Agreement Resolving Patent Litigation Relating to JELMYTO® (mitomycin) for pyelocalyceal solution - GlobeNewsWire
- 25 days ago - UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - UroGen Pharma Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 5 weeks ago - UroGen Pharma Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 6 weeks ago - UroGen Pharma reports month results from UTOPIA trial - TheFly